Search

Rajesh R Wakaskar

age ~39

from Woburn, MA

Get Report
Connected to:

Rajesh Wakaskar Phones & Addresses

  • Woburn, MA
  • Waltham, MA
  • Watertown, MA
  • Chandler, AZ
  • Omaha, NE

Work

  • Company:
    Department of pharmaceutical sciences for pharm d
    2009
  • Position:
    Teaching assistant

Education

  • School / High School:
    University of Nebraska Medical Center- Omaha, NE
    2009
  • Specialities:
    PhD in Pharmaceutical Sciences

Us Patents

  • Methods Of Stabilizing Epinephrine

    view source
  • US Patent:
    20190209494, Jul 11, 2019
  • Filed:
    Jan 8, 2019
  • Appl. No.:
    16/242101
  • Inventors:
    - Chandler AZ, US
    Rajesh Wakaskar - Chandler AZ, US
    Chandeshwari Chilampalli - Chandler AZ, US
    Venkat R. Goskonda - Phoenix AZ, US
  • International Classification:
    A61K 31/137
    A61K 47/02
    A61K 47/18
    A61K 47/10
    A61K 9/00
    A61J 1/00
  • Abstract:
    The present invention is directed to methods of stabilizing a pharmaceutical composition comprising epinephrine containing the steps filling a container, capping the container, assembling the container and placing the assembled capped container (assembled device) in a secondary packaging system.

  • Methods Of Stabilizing Dronabinol

    view source
  • US Patent:
    20190209517, Jul 11, 2019
  • Filed:
    Jan 8, 2019
  • Appl. No.:
    16/242098
  • Inventors:
    - Chandler AZ, US
    Rajesh Wakaskar - Chandler AZ, US
    Rachana Inavolu - Chandler AZ, US
    Venkat R. Goskonda - Phoenix AZ, US
  • International Classification:
    A61K 31/352
    A61K 9/00
    A61K 47/10
    A61K 47/14
    A61K 47/18
    A61J 1/00
  • Abstract:
    The present invention is directed to methods of stabilizing an oral pharmaceutical composition comprising dronabinol containing the steps filling a container, capping the container and placing the capped container in a secondary packaging system.

  • Sublingual Opioid Formulations Containing Naloxone

    view source
  • US Patent:
    20190209540, Jul 11, 2019
  • Filed:
    Mar 12, 2019
  • Appl. No.:
    16/299444
  • Inventors:
    - Chandler AZ, US
    Rajesh R. Wakaskar - Chandler AZ, US
    Edwin A. Baldwin - Tempe AZ, US
    Andrew B. Schlinkert - Scottsdale AZ, US
    Min Wu - Chandler AZ, US
    Ningxin Yan - Chandler AZ, US
  • International Classification:
    A61K 31/4468
    A61K 47/26
    A61K 31/485
    A61K 47/10
    A61K 9/00
  • Abstract:
    Sublingual formulations containing an opioid, preferably, fentanyl or a pharmaceutically acceptable salt or ester thereof, naloxone or a pharmaceutically acceptable salt or ester thereof, and a terpene; as well as methods of treating pain by administering the formulations of the invention to a patient in need thereof.

  • Sublingual Fentanyl Formulations Containing A Permeation Enhancer

    view source
  • US Patent:
    20170340557, Nov 30, 2017
  • Filed:
    May 26, 2017
  • Appl. No.:
    15/606125
  • Inventors:
    - Chandler AZ, US
    Rajesh R. Wakaskar - Chandler AZ, US
    Edwin A. Baldwin - Tempe AZ, US
    Andrew B. Schlinkert - Scottsdale AZ, US
    Min Wu - Chandler AZ, US
    Ningxin Yan - Chandler AZ, US
  • International Classification:
    A61K 9/00
    A61K 31/4468
    A61K 47/10
    A61K 47/12
  • Abstract:
    Sublingual formulations containing fentanyl, a pharmaceutically acceptable salt or ester thereof, ethanol, propylene glycol and menthol, as well as methods of treating pain by administering the formulations of the invention to a patient in need thereof.

  • Sublingual Opioid Formulations Containing Naloxone

    view source
  • US Patent:
    20170340620, Nov 30, 2017
  • Filed:
    May 26, 2017
  • Appl. No.:
    15/606146
  • Inventors:
    - Chandler AZ, US
    Rajesh R. Wakaskar - Chandler AZ, US
    Edwin A. Baldwin - Tempe AZ, US
    Andrew B. Schlinkert - Scottsdale AZ, US
    Min Wu - Chandler AZ, US
    Ningxin Yan - Chandler AZ, US
  • International Classification:
    A61K 31/4468
    A61K 9/00
    A61K 31/485
    A61K 47/10
  • Abstract:
    Sublingual formulations containing an opioid, preferably, fentanyl or a pharmaceutically acceptable salt or ester thereof, naloxone or a pharmaceutically acceptable salt or ester thereof, and a terpene; as well as methods of treating pain by administering the formulations of the invention to a patient in need thereof.

Resumes

Rajesh Wakaskar Photo 1

Senior Formulation Scientist

view source
Work:

Senior Formulation Scientist
Rajesh Wakaskar Photo 2

Rajesh Wakaskar Omaha, NE

view source
Work:
Department of Pharmaceutical Sciences for Pharm D

2009 to 2010
Teaching Assistant Clinical Dictionary Coder in Tata Consultancy Services

2008 to 2008 Innovative Project Design by University of Mumbai
Mumbai, Maharashtra
2007 to 2007 Bachelors of Pharmaceutical Sciences
Mumbai, Maharashtra
2007 to 2007 Food, Drugs & Chemicals (FDC) Limited

2006 to 2006
Research Associate trainee Bachelors of Pharmaceutical Sciences
Mumbai, Maharashtra
2004 to 2006
Education:
University of Nebraska Medical Center
Omaha, NE
2009 to 2000
PhD in Pharmaceutical Sciences University of Mumbai
2003 to 2007
Bachelor's in Pharmaceutical Sciences

Googleplus

Rajesh Wakaskar Photo 3

Rajesh Wakaskar

Facebook

Rajesh Wakaskar Photo 4

Rajesh Wakaskar

view source
Get Report for Rajesh R Wakaskar from Woburn, MA, age ~39
Control profile